Page last updated: 2024-09-04

vx 497 and telaprevir

vx 497 has been researched along with telaprevir in 1 studies

Compound Research Comparison

Studies
(vx 497)
Trials
(vx 497)
Recent Studies (post-2010)
(vx 497)
Studies
(telaprevir)
Trials
(telaprevir)
Recent Studies (post-2010) (telaprevir)
2537985136835

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)telaprevir (IC50)
NS3 protease 0.9757
Cathepsin L2Homo sapiens (human)1.35
ProthrombinHomo sapiens (human)1
PlasminogenHomo sapiens (human)8.7
Procathepsin LHomo sapiens (human)3.5
Cathepsin BHomo sapiens (human)2.3033
Neutrophil elastaseHomo sapiens (human)5.56
ChymaseHomo sapiens (human)0.026
Cathepsin SHomo sapiens (human)0.3
Cathepsin KHomo sapiens (human)0.63
Chymotrypsin-like elastase family member 1Homo sapiens (human)0.03

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and telaprevir

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023